HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation

Journal of Leukocyte Biology

Volumn 87, Issue 2, 2010, Pages 223-235

  Del Rio, M L ^a   Lucas, C L ^b   Buhler, L ^b,c   Rayat, G ^d   Rodriguez Barbosa, J I ^a  

^a Laboratory of Immunobiology   (Spain)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Autoimmunity; Coinhibition; Costimulation; Transplantation

Indexed keywords

ANTIGEN; B AND T LYMPHOCYTE ATTENUATOR MONOCLONAL ANTIBODY; CD160 ANTIGEN; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; HERPESVIRUS ENTRY MEDIATOR LIGAND; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; CARDIAC GRAFT REJECTION; CHEMICAL STRUCTURE; CYTOKINE PRODUCTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOBIOLOGY; IMMUNOREGULATION; IMMUNOSTIMULATION; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD; AUTOIMMUNE DISEASES; GRAFT REJECTION; HUMANS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

EID: 76149129007     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0809590     Document Type: Review

References (95)

1. Cai, G., Anumanthan, A., Brown, J. A., Greenfield, E. A., Zhu, B., Freeman, G. J. (2008) CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat. Immunol. 9, 176-185.
2. Abbas, A. K., Murphy, K. M., Sher, A. (1996) Functional diversity of helper T lymphocytes. Nature 383, 787-793.
3. Parish, I. A., Kaech, S. M. (2009) Diversity in CD8(+) T cell differentiation. Curr. Opin. Immunol. 21, 291-297.
4. Zhou, L., Chong, M. M., Littman, D. R. (2009) Plasticity of CD4+ T cell lineage differentiation. Immunity 30, 646-655.
5. Salomon, B., Bluestone, J. A. (2001) Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19, 225-252.
6. Li, X. C., Rothstein, D. M., Sayegh, M. H. (2009) Costimulatory pathways in transplantation: challenges and new developments. Immunol. Rev. 229, 271-293.
7. Weaver, T. A., Charafeddine, A. H., Kirk, A. D. (2008) Costimulation blockade: towards clinical application. Front. Biosci. 13, 2120-2139.
8. Schwartz, R. H. (2003) T cell anergy. Annu. Rev. Immunol. 21, 305-334.
9. Kroczek, R. A., Mages, H. W., Hutloff, A. (2004) Emerging paradigms of T-cell co-stimulation. Curr. Opin. Immunol. 16, 321-327.
10. Watts, T. H. (2005) TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23, 23-68.
11. Adams, A. B., Larsen, C. P., Pearson, T. C., Newell, K. A. (2002) The role of TNF receptor and TNF superfamily molecules in organ transplantation. Am. J. Transplant. 2, 12-18.
12. Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., Bluestone, J. A. (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405-413.
13. Ishida, Y., Agata, Y., Shibahara, K., Honjo, T. (1992) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887-3895.
14. Watanabe, N., Gavrieli, M., Sedy, J. R., Yang, J., Fallarino, F., Loftin, S. K., Hurchla, M. A., Zimmerman, N., Sim, J., Zang, X., Murphy, T. L., Russell, J. H., Allison, J. P., Murphy, K. M. (2003) BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4, 670-679.
15. Maeda, M., Carpenito, C., Russell, R. C., Dasanjh, J., Veinotte, L. L., Ohta, H., Yamamura, T., Tan, R., Takei, F. (2005) Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and nonclassical MHC class I and regulates NK cell activation. J. Immunol. 175, 4426-4432.
16. Locksley, R. M., Killeen, N., Lenardo, M. J. (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487-501.
17. Croft, M. (2005) The evolving crosstalk between co-stimulatory and coinhibitory receptors: HVEM-BTLA. Trends Immunol. 26, 292-294.
18. Han, P., Goularte, O. D., Rufner, K., Wilkinson, B., Kaye, J. (2004) An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J. Immunol. 172, 5931-5939.
19. Gonzalez, L. C., Loyet, K. M., Calemine-Fenaux, J., Chauhan, V., Wranik, B., Ouyang, W., Eaton, D. L. (2005) A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc. Natl. Acad. Sci. USA 102, 1116-1121.
20. Compaan, D. M., Gonzalez, L. C., Tom, I., Loyet, K. M., Eaton, D., Hymowitz, S. G. (2005) Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex. J. Biol. Chem. 280, 39553-39561.
21. Chemnitz, J. M., Lanfranco, A. R., Braunstein, I., Riley, J. L. (2006) B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs. J. Immunol. 176, 6603-6614.
22. Hsu, H., Solovyev, I., Colombero, A., Elliott, R., Kelley, M., Boyle, W. J. (1997) ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J. Biol. Chem. 272, 13471-13474.
23. Montgomery, R. I., Warner, M. S., Lum, B. J., Spear, P. G. (1996) Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/ NGF receptor family. Cell 87, 427-436.
24. Whitbeck, J. C., Peng, C., Lou, H., Xu, R., Willis, S. H., Ponce de Leon, M., Peng, T., Nicola, A. V., Montgomery, R. I., Warner, M. S., Soulika, A. M., Spruce, L. A., Moore, W. T., Lambris, J. D., Spear, P. G., Cohen, G. H., Eisenberg, R. J. (1997) Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J. Virol. 71, 6083-6093.
25. Sedy, J. R., Gavrieli, M., Potter, K. G., Hurchla, M. A., Lindsley, R. C., Hildner, K., Scheu, S., Pfeffer, K., Ware, C. F., Murphy, T. L., Murphy, K. M. (2005) B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6, 90-98.
26. Mauri, D. N., Ebner, R., Montgomery, R. I., Kochel, K. D., Cheung, T. C., Yu, G. L., Ruben, S., Murphy, M., Eisenberg, R. J., Cohen, G. H., Spear, P. G., Ware, C. F. (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator. Immunity 8, 21-30.
27. Cai, G., Freeman, G. J. (2009) The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol. Rev. 229, 244-258.
28. Bodmer, J. L., Schneider, P., Tschopp, J. (2002) The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19-26.
29. Rooney, I. A., Butrovich, K. D., Glass, A. A., Borboroglu, S., Benedict, C. A., Whitbeck, J. C., Cohen, G. H., Eisenberg, R. J., Ware, C. F. (2000) The lymphotoxin-β receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. J. Biol. Chem. 275, 14307-14315.
30. Ware, C. F. (2008) Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol. Rev. 223, 186-201.
31. Cheung, T. C., Humphreys, I. R., Potter, K. G., Norris, P. S., Shumway, H. M., Tran, B. R., Patterson, G., Jean-Jacques, R., Yoon, M., Spear, P. G., Murphy, K. M., Lurain, N. S., Benedict, C. A., Ware, C. F. (2005) Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc. Natl. Acad. Sci. USA 102, 13218-13223.
32. Marsters, S. A., Ayres, T. M., Skubatch, M., Gray, C. L., Rothe, M., Ashkenazi, A. (1997) Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-κB and AP-1. J. Biol. Chem. 272, 14029-14032.
33. Tamada, K., Shimozaki, K., Chapoval, A. I., Zhai, Y., Su, J., Chen, S. F., Hsieh, S. L., Nagata, S., Ni, J., Chen, L. (2000) LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cellmediated allogeneic T cell response. J. Immunol. 164, 4105-4110.
34. Morel, Y., Schiano de Colella, J. M., Harrop, J., Deen, K. C., Holmes, S. D., Wattam, T. A., Khandekar, S. S., Truneh, A., Sweet, R. W., Gastaut, J. A., Olive, D., Costello, R. T. (2000) Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J. Immunol. 165, 4397-4404.
35. Duhen, T., Pasero, C., Mallet, F., Barbarat, B., Olive, D., Costello, R. T. (2004) LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation. Eur. J. Immunol. 34, 3534-3541.
36. Gavrieli, M., Sedy, J., Nelson, C. A., Murphy, K. M. (2006) BTLA and HVEM cross talk regulates inhibition and costimulation. Adv. Immunol. 92, 157-185.
37. Fan, Z., Yu, P., Wang, Y., Wang, Y., Fu, M. L., Liu, W., Sun, Y., Fu, Y. X. (2006) NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors. Blood 107, 1342-1351.
38. Wang, Y., Subudhi, S. K., Anders, R. A., Lo, J., Sun, Y., Blink, S., Wang, J., Liu, X., Mink, K., Degrandi, D., Pfeffer, K., Fu, Y. X. (2005) The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J. Clin. Invest. 115, 711-717.
39. Harrop, J. A., McDonnell, P. C., Brigham-Burke, M., Lyn, S. D., Minton, J., Tan, K. B., Dede, K., Spampanato, J., Silverman, C., Hensley, P., DiPrinzio, R., Emery, J. G., Deen, K., Eichman, C., Chabot-Fletcher, M., Truneh, A., Young, P. R. (1998) Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J. Biol. Chem. 273, 27548-27556.
40. Wan, X., Zhang, J., Luo, H., Shi, G., Kapnik, E., Kim, S., Kanakaraj, P., Wu, J. (2002) A TNF family member LIGHT transduces costimulatory signals into human T cells. J. Immunol. 169, 6813-6821.
41. Shi, G., Luo, H., Wan, X., Salcedo, T. W., Zhang, J., Wu, J. (2002) Mouse T cells receive costimulatory signals from LIGHT, a TNF family member. Blood 100, 3279-3286.
42. Granger, S. W., Butrovich, K. D., Houshmand, P., Edwards, W. R., Ware, C. F. (2001) Genomic characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis. J. Immunol. 167, 5122-5128.
43. Yu, K. Y., Kwon, B., Ni, J., Zhai, Y., Ebner, R., Kwon, B. S. (1999) A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J. Biol. Chem. 274, 13733-13736.
44. Granger, S. W., Rickert, S. (2003) LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev. 14, 289-296.
45. Scheu, S., Alferink, J., Potzel, T., Barchet, W., Kalinke, U., Pfeffer, K. (2002) Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin β in mesenteric lymph node genesis. J. Exp. Med. 195, 1613-1624.
46. Force, W. R., Walter, B. N., Hession, C., Tizard, R., Kozak, C. A., Browning, J. L., Ware, C. F. (1995) Mouse lymphotoxin-β receptor. Molecular genetics, ligand binding, and expression. J. Immunol. 155, 5280-5288.
47. Morel, Y., Truneh, A., Sweet, R. W., Olive, D., Costello, R. T. (2001) The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J. Immunol. 167, 2479-2486.
48. Ye, Q., Fraser, C. C., Gao, W., Wang, L., Busfield, S. J., Wang, C., Qiu, Y., Coyle, A. J., Gutierrez-Ramos, J. C., Hancock, W. W. (2002) Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J. Exp. Med. 195, 795-800.
49. Shaikh, R. B., Santee, S., Granger, S. W., Butrovich, K., Cheung, T., Kronenberg, M., Cheroutre, H., Ware, C. F. (2001) Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J. Immunol. 167, 6330-6337.
50. Wang, J., Lo, J. C., Foster, A., Yu, P., Chen, H. M., Wang, Y., Tamada, K., Chen, L., Fu, Y. X. (2001) The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J. Clin. Invest. 108, 1771-1780.
51. Pierer, M., Schulz, A., Rossol, M., Kendzia, E., Kyburz, D., Haentzschel, H., Baerwald, C., Wagner, U. (2009) Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model. J. Immunol. 182, 3139-3145.
52. Tamada, K., Shimozaki, K., Chapoval, A. I., Zhu, G., Sica, G., Flies, D., Boone, T., Hsu, H., Fu, Y. X., Nagata, S., Ni, J., Chen, L. (2000) Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat. Med. 6, 283-289.
53. Xu, Y., Flies, A. S., Flies, D. B., Zhu, G., Anand, S., Flies, S. J., Xu, H., Anders, R. A., Hancock, W. W., Chen, L., Tamada, K. (2007) Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease. Blood 109, 4097-4104.
54. Fan, K., Wang, H., Wei, H., Zhou, Q., Kou, G., Hou, S., Qian, W., Dai, J., Li, B., Zhang, Y., Zhu T., Guo Y. (2007) Blockade of LIGHT/HVEM and B7/CD28 signaling facilitates long-term islet graft survival with development of allospecific tolerance. Transplantation 84, 746-754.
55. Liu, J., Schmidt, C. S., Zhao, F., Okragly, A. J., Glasebrook, A., Fox, N., Galbreath, E., Zhang, Q., Song, H. Y., Na, S., Yang, D. D. (2003) LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function. Int. Immunol. 15, 861-870.
56. Gavrieli, M., Watanabe, N., Loftin, S. K., Murphy, T. L., Murphy, K. M. (2003) Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Biochem. Biophys. Res. Commun. 312, 1236-1243.
57. Vendel, A. C., Calemine-Fenaux, J., Izrael-Tomasevic, A., Chauhan, V., Arnott, D., Eaton, D. L. (2009) B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK. J. Immunol. 182, 1509-1517.
58. Hurchla, M. A., Sedy, J. R., Gavrieli, M., Drake, C. G., Murphy, T. L., Murphy, K. M. (2005) B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly induced in anergic CD4+ T cells. J. Immunol. 174, 3377-3385.
59. low cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants. Immunobiology, Epub ahead of print.
60. Otsuki, N., Kamimura, Y., Hashiguchi, M., Azuma, M. (2006) Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells. Biochem. Biophys. Res. Commun. 344, 1121-1127.
61. Zang, X., Loke, P., Kim, J., Murphy, K., Waitz, R., Allison, J. P. (2003) B7x: a widely expressed B7 family member that inhibits T cell activation. Proc. Natl. Acad. Sci. USA 100, 10388-10392.
62. Krieg, C., Han, P., Stone, R., Goularte, O. D., Kaye, J. (2005) Functional analysis of B and T lymphocyte attenuator engagement on CD4+ and CD8+ T cells. J. Immunol. 175, 6420-6427.
63. Oya, Y., Watanabe, N., Owada, T., Oki, M., Hirose, K., Suto, A., Kagami, S., Nakajima, H., Kishimoto, T., Iwamoto, I., Murphy, T. L., Murphy, K. M., Saito, Y. (2008) Development of autoimmune hepatitis-like disease and production of autoantibodies to nuclear antigens in mice lacking B and T lymphocyte attenuator. Arthritis Rheum. 58, 2498-2510.
64. Krieg, C., Boyman, O., Fu, Y. X., Kaye, J. (2007) B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation. Nat. Immunol. 8, 162-171.
65. Cheung, T. C., Steinberg, M. W., Oborne, L. M., Macauley, M. G., Fukuyama, S., Sanjo, H., D'Souza, C., Norris, P. S., Pfeffer, K., Murphy, K. M., Kronenberg, M., Spear, P. G., Ware, C. F. (2009) Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc. Natl. Acad. Sci. USA 106, 6244-6249.
66. Auchincloss Jr., H., Mayer, T., Ghobrial, R., Winn, H. J. (1989) T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection. Immunol. Res. 8, 149-164.
67. Yamada, A., Laufer, T. M., Gerth, A. J., Chase, C. M., Colvin, R. B., Russell, P. S., Sayegh, M. H., Auchincloss Jr., H. (2003) Further analysis of the T-cell subsets and pathways of murine cardiac allograft rejection. Am. J. Transplant. 3, 23-27.
68. Corry, R. J., Winn, H. J., Russell, P. S. (1973) Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16, 343-350.
69. Tao, R., Wang, L., Han, R., Wang, T., Ye, Q., Honjo, T., Murphy, T. L., Murphy, K. M., Hancock, W. W. (2005) Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J. Immunol. 175, 5774-5782.
70. Le Moine, A., Goldman, M., Abramowicz, D. (2002) Multiple pathways to allograft rejection. Transplantation 73, 1373-1381.
71. Prowse, S. J., Lafferty, K. J., Simeonovic, C. J., Agostino, M., Bowen, K. M., Steele, E. J. (1982) The reversal of diabetes by pancreatic islet transplantation. Diabetes 31 (Suppl. 4), 30-38.
72. Wang, Y., Pontesilli, O., Gill, R. G., La Rosa, F. G., Lafferty, K. J. (1991) The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice. Proc. Natl. Acad. Sci. USA 88, 527-531.
73. Benhamou, P. Y. (2002) Immunomodulation with CTLA4-Ig in islet transplantation. Transplantation 73, S40-S42.
74. Truong, W., Plester, J. C., Hancock, W. W., Kaye, J., Merani, S., Murphy, K. M., Murphy, T. L., Anderson, C. C., Shapiro, A. M. (2007) Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival. Transplantation 84, 1368-1372.
75. Truong, W., Plester, J. C., Hancock, W. W., Merani, S., Murphy, T. L., Murphy, K. M., Kaye, J., Anderson, C. C., Shapiro, A. M. (2007) Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts. Am. J. Transplant. 7, 2663-2674.
76. Truong, W., Hancock, W. W., Anderson, C. C., Merani, S., Shapiro, A. M. (2006) Coinhibitory T-cell signaling in islet allograft rejection and tolerance. Cell Transplant. 15, 105-119.
77. Ferrara, J. L., Cooke, K. R., Pan, L., Krenger, W. (1996) The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 14, 473-489.
78. Shlomchik, W. D. (2007) Graft-versus-host disease. Nat. Rev. Immunol. 7, 340-352.
79. Tschetter, J. R., Mozes, E., Shearer, G. M. (2000) Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J. Immunol. 165, 5987-5994.
80. Hurchla, M. A., Sedy, J. R., Murphy, K. M. (2007) Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation. J. Immunol. 178, 6073-6082.
81. Blazar, B. R., Carreno, B. M., Panoskaltsis-Mortari, A., Carter, L., Iwai, Y., Yagita, H., Nishimura, H., Taylor, P. A. (2003) Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-γ-dependent mechanism. J. Immunol. 171, 1272-1277.
82. Habicht, A., Kewalaramani, R., Vu, M. D., Demirci, G., Blazar, B. R., Sayegh, M. H., Li, X. C. (2007) Striking dichotomy of PD-L1 and PD-L2 pathways in regulating alloreactive CD4(+) and CD8(+) T cells in vivo. Am. J. Transplant. 7, 2683-2692.
83. Tao, R., Wang, L., Murphy, K. M., Fraser, C. C., Hancock, W. W. (2008) Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells. J. Immunol. 180, 6649-6655.
84. Maiza, H., Leca, G., Mansur, I. G., Schiavon, V., Boumsell, L., Bensussan, A. (1993) A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J. Exp. Med. 178, 1121-1126.
85. Anumanthan, A., Bensussan, A., Boumsell, L., Christ, A. D., Blumberg, R. S., Voss, S. D., Patel, A. T., Robertson, M. J., Nadler, L. M., Freeman, G. J. (1998) Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J. Immunol. 161, 2780-2790.
86. Giustiniani, J., Bensussan, A., Marie-Cardine, A. (2009) Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation. J. Immunol. 182, 63-71.
87. Abecassis, S., Giustiniani, J., Meyer, N., Schiavon, V., Ortonne, N., Campillo, J. A., Bagot, M., Bensussan, A. (2007) Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation. J. Invest. Dermatol. 127, 1161-1166.
88. Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., Ahmed, R. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682-687.
89. Okazaki, T., Honjo, T. (2006) Rejuvenating exhausted T cells during chronic viral infection. Cell 124, 459-461.
90. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., Mncube, Z., Duraiswamy, J., Zhu, B., Eichbaum, Q., Altfeld, M., Wherry, E. J., Coovadia, H. M., Goulder, P. J., Klenerman, P., Ahmed, R., Freeman, G. J., Walker, B. D. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350-354.
91. Agrawal, S., Marquet, J., Freeman, G. J., Tawab, A., Bouteiller, P. L., Roth, P., Bolton, W., Ogg, G., Boumsell, L., Bensussan, A. (1999) Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J. Immunol. 162, 1223-1226.
92. Le Bouteiller, P., Barakonyi, A., Giustiniani, J., Lenfant, F., Marie-Cardine, A., Aguerre-Girr, M., Rabot, M., Hilgert, I., Mami-Chouaib, F., Tabiasco, J., Boumsell, L., Bensussan, A. (2002) Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc. Natl. Acad. Sci. USA 99, 16963-16968.
93. Barakonyi, A., Rabot, M., Marie-Cardine, A., Aguerre-Girr, M., Polgar, B., Schiavon, V., Bensussan, A., Le Bouteiller, P. (2004) Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J. Immunol. 173, 5349-5354.
94. Tsujimura, K., Obata, Y., Matsudaira, Y., Nishida, K., Akatsuka, Y., Ito, Y., Demachi-Okamura, A., Kuzushima, K., Takahashi, T. (2006) Characterization of murine CD160+ CD8+ T lymphocytes. Immunol. Lett. 106, 48-56.
95. Nelson, C. A., Fremont, M. D., Sedy, J. R., Norris, P. S., Ware, C. F., Murphy, K. M., Fremont, D. H. (2008) Structural determinants of herpesvirus entry mediator recognition by murine B and T lymphocyte attenuator. J. Immunol. 180, 940-947.